MedPath

The efficacy of nasal airway stent (nastentTM) in patient with obstructive sleep apnea

Not Applicable
Conditions
obstructive sleep apnea
Registration Number
JPRN-UMIN000024617
Lead Sponsor
Division for Oral and Facial Disorders, Osaka University Dental Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have a neuromuscular disease, severe heart disease and mental disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change of apnea hypopnea index (AHI) after one month treatment of nastent.
Secondary Outcome Measures
NameTimeMethod
The change of minimum SpO2 after one month treatment of nastent.
© Copyright 2025. All Rights Reserved by MedPath